{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:50:49Z","timestamp":1772211049457,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coagulopathies are common in intensive therapy units (ITUs) and may represent both the cause and the consequence of a critically ill status. Because coagulopathies are associated with increased complications in terms of both increased ischemic and bleeding events, the prevention, assessment, and treatment of these clinical conditions are important issues to be considered in the ITU. In this review, we explore the pathophysiological mechanisms, discuss the most common causes, and provide practical recommendations on the assessment and treatment of coagulopathies in the ITU.<\/jats:p>","DOI":"10.1093\/ehjacc\/zuad051","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T17:24:48Z","timestamp":1683912288000},"page":"399-407","source":"Crossref","is-referenced-by-count":7,"title":["The evaluation and management of coagulopathies in the intensive therapy units"],"prefix":"10.1093","volume":"12","author":[{"given":"Mattia","family":"Galli","sequence":"first","affiliation":[{"name":"GVM Care & Research, Maria Cecilia Hospital , Cotignola , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick J","family":"Angiolillo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Florida College of Medicine , 655 West 8th Street, Jacksonville, FL 32209 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"2023060210072403400_zuad051-B1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMra1208626","article-title":"Bleeding and coagulopathies in critical care","volume":"370","author":"Hunt","year":"2014","journal-title":"N Engl J Med"},{"key":"2023060210072403400_zuad051-B2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc4975","article-title":"Coagulation abnormalities in critically ill patients","volume":"10","author":"Levi","year":"2006","journal-title":"Critical Care"},{"key":"2023060210072403400_zuad051-B3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2141.1996.5101050.x","article-title":"The incidence and cause of coagulopathies in an intensive care population","volume":"93","author":"Chakraverty","year":"1996","journal-title":"Br J Haematol"},{"key":"2023060210072403400_zuad051-B4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"2023060210072403400_zuad051-B5","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2174\/0929867043364603","article-title":"The hemostatic system","volume":"11","author":"Stassen","year":"2004","journal-title":"Curr Med Chem"},{"key":"2023060210072403400_zuad051-B6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-4431.2009.00389.x","article-title":"The cell-based model of coagulation","volume":"19","author":"Smith","year":"2009","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2023060210072403400_zuad051-B7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023060210072403400_zuad051-B8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1253\/circj.CJ-09-0982","article-title":"Basic principles of platelet biology and clinical implications","volume":"74","author":"Angiolillo","year":"2010","journal-title":"Circ J"},{"key":"2023060210072403400_zuad051-B9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"2023060210072403400_zuad051-B10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2023060210072403400_zuad051-B11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1160\/TH14-12-1067","article-title":"The role of platelets in inflammation","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb Haemost"},{"key":"2023060210072403400_zuad051-B12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1537-2995.2012.03866.x","article-title":"Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study","volume":"53","author":"Stanworth","year":"2013","journal-title":"Transfusion"},{"key":"2023060210072403400_zuad051-B13","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1378\/chest.08-2534","article-title":"Coagulopathy in critically ill patients: part 1: platelet disorders","volume":"136","author":"Rice","year":"2009","journal-title":"Chest"},{"key":"2023060210072403400_zuad051-B14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2021.12.007","article-title":"Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention","volume":"33","author":"Galli","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"2023060210072403400_zuad051-B15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.08-2535","article-title":"Coagulopathy in critically ill patients: part 2: soluble clotting factors and hemostatic testing","volume":"137","author":"Wheeler","year":"2010","journal-title":"Chest"},{"key":"2023060210072403400_zuad051-B16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","article-title":"Early coagulopathy predicts mortality in trauma","volume":"55","author":"MacLeod","year":"2003","journal-title":"J Trauma"},{"key":"2023060210072403400_zuad051-B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-62703-339-8_19","article-title":"Anti-factor Xa (anti-Xa) assay","volume":"992","author":"Newall","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2023060210072403400_zuad051-B18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0030-1265289","article-title":"Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography","volume":"36","author":"Gonzalez","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"2023060210072403400_zuad051-B19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/SLA.0000000000001608","article-title":"Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays","volume":"263","author":"Gonzalez","year":"2016","journal-title":"Ann Surg"},{"key":"2023060210072403400_zuad051-B20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2023060210072403400_zuad051-B21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40560-019-0387-z","article-title":"Sepsis-associated disseminated intravascular coagulation and its differential diagnoses","volume":"7","author":"Iba","year":"2019","journal-title":"J Intensive Care"},{"key":"2023060210072403400_zuad051-B22","doi-asserted-by":"crossref","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"2023060210072403400_zuad051-B23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jtha.2022.10.022","article-title":"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis","volume":"21","author":"Iba","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2023060210072403400_zuad051-B24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"2023060210072403400_zuad051-B25","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"2023060210072403400_zuad051-B26","doi-asserted-by":"crossref","first-page":"e019650","DOI":"10.1161\/JAHA.120.019650","article-title":"Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management","volume":"10","author":"Ortega-Paz","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023060210072403400_zuad051-B27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ehjcvp\/pvab070","article-title":"Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Ortega-Paz","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023060210072403400_zuad051-B28","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1093\/ehjcvp\/pvac010","article-title":"Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19","volume":"8","author":"Ortega-Paz","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023060210072403400_zuad051-B29","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/eurheartj\/ehac294","article-title":"Great debate: triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week","volume":"43","author":"De Caterina","year":"2022","journal-title":"Eur Heart J"},{"key":"2023060210072403400_zuad051-B30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.31083\/j.rcm2308286","article-title":"Bleeding complications in patients undergoing percutaneous coronary intervention","volume":"23","author":"Galli","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"2023060210072403400_zuad051-B31","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100047","article-title":"Bentracimab for ticagrelor reversal in patients undergoing urgent surgery","volume":"1","author":"Bhatt","year":"2022","journal-title":"NEJM Evid"},{"key":"2023060210072403400_zuad051-B32","doi-asserted-by":"crossref","first-page":"975969","DOI":"10.3389\/fcvm.2022.975969","article-title":"De-escalation of antiplatelet therapy in acute coronary syndromes: why, how and when?","volume":"9","author":"Galli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023060210072403400_zuad051-B33","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo","year":"2022","journal-title":"EuroIntervention"},{"key":"2023060210072403400_zuad051-B34","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"2023060210072403400_zuad051-B35","doi-asserted-by":"crossref","first-page":"53s","DOI":"10.1378\/chest.127.2_suppl.53S","article-title":"Immune thrombocytopenia caused by glycoprotein IIb\/IIIa inhibitors","volume":"127","author":"Aster","year":"2005","journal-title":"Chest"},{"key":"2023060210072403400_zuad051-B36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"2023060210072403400_zuad051-B37","doi-asserted-by":"publisher","first-page":"qcac076","DOI":"10.1093\/ehjqcco\/qcac076","article-title":"Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis","author":"Cappannoli","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023060210072403400_zuad051-B38","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/jth.15889","article-title":"ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation","volume":"20","author":"Deconinck","year":"2022","journal-title":"J Thromb Haemost"},{"key":"2023060210072403400_zuad051-B39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2023060210072403400_zuad051-B40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"key":"2023060210072403400_zuad051-B41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","article-title":"How to manage coagulopathies in critically ill patients","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuad051\/50451802\/zuad051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/12\/6\/399\/50507961\/zuad051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/12\/6\/399\/50507961\/zuad051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T21:25:33Z","timestamp":1685741133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/12\/6\/399\/7161007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,12]]},"published-print":{"date-parts":[[2023,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuad051","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,5,12]]}}}